Limited penetration of posaconazole into cerebrospinal fluid in an allogeneic stem cell recipient with invasive pulmonary aspergillosis

Bone Marrow Transplant. 2009 Aug;44(4):269-70. doi: 10.1038/bmt.2009.17. Epub 2009 Feb 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Antifungal Agents / administration & dosage
  • Antifungal Agents / cerebrospinal fluid*
  • Antifungal Agents / pharmacokinetics
  • Aspergillosis / cerebrospinal fluid*
  • Aspergillosis / drug therapy*
  • Central Nervous System Fungal Infections / cerebrospinal fluid
  • Central Nervous System Fungal Infections / drug therapy
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Leukemia, Myeloid / therapy
  • Lung Diseases, Fungal / cerebrospinal fluid*
  • Lung Diseases, Fungal / drug therapy*
  • Male
  • Triazoles / administration & dosage
  • Triazoles / cerebrospinal fluid*
  • Triazoles / pharmacokinetics
  • Young Adult

Substances

  • Antifungal Agents
  • Triazoles
  • posaconazole